Breakthrough study could save more cancer patients
Professor Jeffrey Settleman, from Harvard Medical School, told a conference in Glasgow that resistance to key drugs used to treat lung cancer patients could be tackled after research into what causes people to stop responding to treatment.
This entry was posted on Friday, June 23rd, 2006 at 8:28 am and is filed under Research, Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.